Ratings by Needham (Gil Blum)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/12/2026 | Artiva Biotherapeutics | ARTV | Maintain | Buy (N/A) |
|
Details | ||
| 5/4/2026 | Celcuity Inc | CELC | Maintain | Buy (N/A) |
|
Details | ||
| 4/10/2026 | Lyell Immunopharma | LYEL | New Coverage | Buy (N/A) |
23.85 (12.63) |
-47.04% | Details | |
| 3/26/2026 | Nkarta Inc. | NKTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2026 | Celcuity Inc | CELC | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2026 | CRISPR Therapeutics | CRSP | Maintain | Buy (N/A) |
|
Details | ||
| 1/13/2026 | Mereo BipPharma Group | MREO | Maintain | Buy (N/A) |
|
Details | ||
| 12/29/2025 | Autolus Therapeutics plc | AUTL | Maintain | Buy (N/A) |
|
Details | ||
| 12/19/2025 | Amicus Therapeutics | FOLD | Downgrade | Hold (Buy) |
10.89 (14.49) |
33.06% | Details | |
| 12/4/2025 | Solid Biosciences | SLDB | New Coverage | Buy (N/A) |
5.19 (8.79) |
69.36% | Details | |
| 11/13/2025 | Absci Corp. | ABSI | Maintain | Buy (N/A) |
|
Details | ||
| 9/18/2025 | Amicus Therapeutics | FOLD | Upgrade | Buy (Hold) |
7.97 (10.89) |
36.64% | Details | |
| 8/15/2025 | Celcuity Inc | CELC | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2025 | Absci Corp. | ABSI | Maintain | Buy (N/A) |
|
Details | ||
| 7/21/2025 | Sarepta Therapeutics | SRPT | Downgrade | Underperform (Hold) |
14.08 (17.26) |
22.59% | Details | |
| 7/18/2025 | Sarepta Therapeutics | SRPT | Downgrade | Hold (Buy) |
21.97 (17.26) |
-21.44% | Details | |
| 7/17/2025 | Sarepta Therapeutics | SRPT | Maintain | Buy (Buy) |
|
Details | ||
| 7/10/2025 | Mereo BipPharma Group | MREO | Maintain | Buy (N/A) |
|
Details | ||
| 6/12/2025 | Fate Therapeutics | FATE | Maintain | Hold (Hold) |
|
Details | ||
| 5/27/2025 | Rocket Pharmaceuticals | RCKT | Downgrade | Hold (Buy) |
6.27 (3.47) |
-44.66% | Details | |
| 5/15/2025 | Nkarta Inc. | NKTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2025 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2025 | CRISPR Therapeutics | CRSP | Maintain | Buy (N/A) |
|
Details | ||
| 4/3/2025 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2025 | Rocket Pharmaceuticals | RCKT | Maintain | Buy (N/A) |
|
Details | ||
| 2/6/2025 | Celcuity Inc | CELC | Maintain | Buy (N/A) |
|
Details | ||
| 1/29/2025 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 1/22/2025 | Absci Corp. | ABSI | New Coverage | Buy (N/A) |
3.22 (7.41) |
130.12% | Details | |
| 11/27/2024 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2024 | Nkarta Inc. | NKTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2024 | Arcellx Inc. | ACLX | Maintain | Buy (N/A) |
|
Details | ||
| 10/2/2024 | Shattuck Labs | STTK | Downgrade | Hold (Buy) |
1.92 (5.39) |
180.73% | Details | |
| 9/4/2024 | Recursion Pharmaceuticals | RXRX | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2024 | Artiva Biotherapeutics | ARTV | New Coverage | Buy (N/A) |
11.22 (9.80) |
-12.66% | Details | |
| 8/8/2024 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2024 | CRISPR Therapeutics | CRSP | Maintain | Buy (N/A) |
|
Details | ||
| 7/12/2024 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 6/25/2024 | G1 Therapeutics | GTHX | Maintain | Buy (N/A) |
|
Details | ||
| 6/12/2024 | Mereo BipPharma Group | MREO | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2024 | Tscan Therapeutics Inc | TCRX | New Coverage | Buy (N/A) |
7.73 (0.92) |
-88.1% | Details | |
| 5/10/2024 | Nkarta Inc. | NKTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2024 | CRISPR Therapeutics | CRSP | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2024 | Mereo BipPharma Group | MREO | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2024 | Celcuity Inc | CELC | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2024 | Taysha Gene Therapies | TSHA | Maintain | Buy (N/A) |
|
Details | ||
| 3/18/2024 | Arcellx Inc. | ACLX | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2024 | Geron Corporation | GERN | Maintain | Buy (N/A) |
|
Details | ||
| 3/7/2024 | Generation Bio | GBIO | Maintain | Buy (N/A) |
|
Details | ||
| 2/29/2024 | Arcellx Inc. | ACLX | Maintain | Buy (N/A) |
|
Details | ||
| 2/29/2024 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2024 | Recursion Pharmaceuticals | RXRX | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2024 | G1 Therapeutics | GTHX | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2024 | Autolus Therapeutics plc | AUTL | Maintain | Buy (N/A) |
|
Details | ||
| 2/8/2024 | I-Mab | IMAB | Maintain | Buy (N/A) |
|
Details | ||
| 1/4/2024 | Arcellx Inc. | ACLX | Maintain | Buy (N/A) |
|
Details | ||
| 12/11/2023 | Arcellx Inc. | ACLX | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2023 | Arcellx Inc. | ACLX | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2023 | CRISPR Therapeutics | CRSP | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2023 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 9/25/2023 | I-Mab | IMAB | Maintain | Buy (N/A) |
|
Details | ||
| 9/13/2023 | Rocket Pharmaceuticals | RCKT | Maintain | Buy (N/A) |
|
Details | ||
| 9/13/2023 | Immunocore Holdings | IMCR | New Coverage | Buy (N/A) |
54.02 (29.20) |
-45.95% | Details | |
| 8/11/2023 | Shattuck Labs | STTK | Maintain | Buy (N/A) |
|
Details | ||
| 5/15/2023 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2023 | CTI BioPharma | CTIC | Downgrade | Hold (Buy) |
4.82 (9.09) |
88.59% | Details | |
| 5/9/2023 | Arcellx Inc. | ACLX | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2023 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 3/16/2023 | Recursion Pharmaceuticals | RXRX | New Coverage | Buy (N/A) |
7.48 (3.16) |
-57.75% | Details | |
| 3/1/2023 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2023 | Shattuck Labs | STTK | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2023 | Generation Bio | GBIO | Maintain | Buy (N/A) |
|
Details | ||
| 2/22/2023 | CRISPR Therapeutics | CRSP | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2023 | G1 Therapeutics | GTHX | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2023 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 1/10/2023 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 1/3/2023 | G1 Therapeutics | GTHX | Maintain | Buy (N/A) |
|
Details | ||
| 12/12/2022 | Arcellx Inc. | ACLX | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2022 | Rocket Pharmaceuticals | RCKT | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2022 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 10/27/2022 | Arcellx Inc. | ACLX | New Coverage | Buy (N/A) |
20.27 (115.07) |
467.69% | Details | |
| 7/28/2022 | Nkarta Inc. | NKTX | New Coverage | Buy (N/A) |
12.84 (3.03) |
-76.4% | Details | |
| 7/28/2022 | Fate Therapeutics | FATE | New Coverage | Hold (N/A) |
33.17 (2.16) |
-93.49% | Details | |
| 7/11/2022 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2022 | Sarepta Therapeutics | SRPT | Maintain | Buy (Buy) |
|
Details | ||
| 6/24/2022 | Sarepta Therapeutics | SRPT | Maintain | Buy (Buy) |
|
Details | ||
| 6/14/2022 | Selecta Biosciences | SELB | Maintain | Buy (N/A) |
|
Details | ||
| 6/6/2022 | CTI BioPharma | CTIC | Maintain | Buy (Buy) |
|
Details | ||
| 6/6/2022 | Mereo BipPharma Group | MREO | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2022 | Aeglea Biotherapeutics | AGLE | Downgrade | Hold (Buy) |
1.50 (12.01) |
700.67% | Details | |
| 5/26/2022 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 5/17/2022 | Avrobio Inc. | AVRO | Maintain | Buy (Buy) |
|
Details | ||
| 5/17/2022 | Celcuity Inc | CELC | Maintain | Buy (Buy) |
|
Details | ||
| 5/17/2022 | Rocket Pharmaceuticals | RCKT | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2022 | CRISPR Therapeutics | CRSP | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2022 | CTI BioPharma | CTIC | Maintain | Buy (Buy) |
|
Details | ||
| 5/10/2022 | Geron Corporation | GERN | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2022 | Rocket Pharmaceuticals | RCKT | Maintain | Buy (Buy) |
|
Details | ||
| 5/6/2022 | Generation Bio | GBIO | Maintain | Buy (Buy) |
|
Details | ||
| 5/5/2022 | Selecta Biosciences | SELB | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2022 | Aeglea Biotherapeutics | AGLE | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2022 | Sarepta Therapeutics | SRPT | Maintain | Buy (Buy) |
|
Details | ||
| 5/4/2022 | G1 Therapeutics | GTHX | Maintain | Buy (N/A) |
|
Details | ||
| 4/18/2022 | Selecta Biosciences | SELB | Maintain | Buy (Buy) |
|
Details | ||
| 4/18/2022 | Autolus Therapeutics plc | AUTL | Maintain | Buy (Buy) |
|
Details | ||
| 4/14/2022 | G1 Therapeutics | GTHX | Maintain | Buy (Buy) |
|
Details | ||
| 4/14/2022 | Mereo BipPharma Group | MREO | Maintain | Buy (Buy) |
|
Details | ||
| 4/12/2022 | Aeglea Biotherapeutics | AGLE | Maintain | Buy (Buy) |
|
Details | ||
| 4/12/2022 | I-Mab | IMAB | Maintain | Buy (Buy) |
|
Details | ||
| 4/12/2022 | Nurix | NRIX | Maintain | Buy (Buy) |
|
Details | ||
| 4/12/2022 | Taysha Gene Therapies | TSHA | Maintain | Buy (Buy) |
|
Details | ||
| 4/12/2022 | Rocket Pharmaceuticals | RCKT | Maintain | Buy (Buy) |
|
Details | ||
| 4/12/2022 | Shattuck Labs | STTK | Maintain | Buy (Buy) |
|
Details | ||
| 4/12/2022 | Generation Bio | GBIO | Maintain | Buy (Buy) |
|
Details | ||
| 4/6/2022 | Genocea Biosciences | GNCA | Maintain | Buy (Buy) |
|
Details | ||
| 3/31/2022 | Taysha Gene Therapies | TSHA | Maintain | Buy (N/A) |
|
Details | ||
| 3/29/2022 | I-Mab | IMAB | Maintain | Buy (Buy) |
|
Details | ||
| 3/24/2022 | Celcuity Inc | CELC | Maintain | Buy (Buy) |
|
Details | ||
| 3/17/2022 | Avrobio Inc. | AVRO | Maintain | Buy (Buy) |
|
Details | ||
| 3/16/2022 | Athersys | ATHX | Maintain | Buy (Buy) |
|
Details | ||
| 3/15/2022 | Shattuck Labs | STTK | Maintain | Buy (N/A) |
|
Details | ||
| 3/14/2022 | Mereo BipPharma Group | MREO | Maintain | Buy (Buy) |
|
Details | ||
| 3/11/2022 | Geron Corporation | GERN | Maintain | Buy (Buy) |
|
Details | ||
| 3/10/2022 | Selecta Biosciences | SELB | Maintain | Buy (Buy) |
|
Details | ||
| 3/10/2022 | Autolus Therapeutics plc | AUTL | Maintain | Buy (Buy) |
|
Details | ||
| 3/2/2022 | Sarepta Therapeutics | SRPT | Maintain | Buy (Buy) |
|
Details | ||
| 3/1/2022 | CTI BioPharma | CTIC | Maintain | Buy (Buy) |
|
Details | ||
| 2/16/2022 | CRISPR Therapeutics | CRSP | Maintain | Buy (Buy) |
|
Details | ||
| 2/4/2022 | Aeglea Biotherapeutics | AGLE | Maintain | Buy (Buy) |
|
Details | ||
| 2/3/2022 | Athersys | ATHX | Maintain | Buy (Buy) |
|
Details | ||
| 1/28/2022 | Nurix | NRIX | Maintain | Buy (Buy) |
|
Details | ||
| 1/4/2022 | Avrobio Inc. | AVRO | Maintain | Buy (N/A) |
|
Details | ||
| 12/15/2021 | Generation Bio | GBIO | Maintain | Buy (N/A) |
|
Details | ||
| 12/1/2021 | CTI BioPharma | CTIC | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2021 | Genocea Biosciences | GNCA | Maintain | Buy (N/A) |
|
Details | ||
| 10/5/2021 | Taysha Gene Therapies | TSHA | Maintain | Buy (N/A) |
|
Details | ||
| 7/16/2021 | Taysha Gene Therapies | TSHA | New Coverage | Buy (N/A) |
20.50 (6.86) |
-66.54% | Details | |
| 5/27/2021 | Amicus Therapeutics | FOLD | New Coverage | Hold (N/A) |
9.00 (7.97) |
-11.44% | Details | |
| 5/27/2021 | Avrobio Inc. | AVRO | New Coverage | Buy (N/A) |
8.05 (1.40) |
-82.61% | Details | |
| 2/18/2021 | Rocket Pharmaceuticals | RCKT | New Coverage | Buy (N/A) |
52.62 (3.47) |
-93.41% | Details | |
| 2/18/2021 | Generation Bio | GBIO | New Coverage | Buy (N/A) |
31.79 (5.34) |
-83.2% | Details |
